XVII International AIDS Conference in Mexico City. Interview with Michel Sidibé who became the Director of UNAIDS in 2009. Here he talks about the importance of the international AIDS conferences for bringing in a human rights perspective on the global HIV/AIDS movement.

XVII International AIDS Conference in Mexico City. Interview in English with the Swedish AIDS Ambassador, Lennart Hjelmåker. He talks about the Swedish contributions at the conference and in the HIV/AIDS response. He also reflects on the next conference in 2010.

XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.

XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.

XVII International AIDS Conference in Mexico City. Interview with Carissa Etienne, Assistant Director-General at WHO and Jim Yong Kim, Professor and since 2012 President of The World Bank. They talk about the leadership of Jonathan Mann and Peter Piot.

XVII International AIDS Conference in Mexico City. Interview with Carissa Etienne, Assistant Director-General at WHO and Jim Yong Kim, Professor and since 2012 President of The World Bank. They talk about the leadership of Jonathan Mann and Peter Piot.

This film tells the US story of the AIDS epidemic starting in the early 1980's. Scientists and activists, both pioneers and youths of today, talk about research, prevention, treatment and care. They also discuss stigma, homophobia and poverty as closely related to HIV and AIDS.

José Esparza is a scientist who has been working many years at WHO and within UNAIDS. He has been known for his work on HIV vaccines. Here he talks about vaccine trials and the future development of vaccines for developing and developed countries.